Atlas Trials

Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H

Clinical trial NCT00048412 · COMPLETED

Trial details

NCT number
NCT00048412
Sponsor
Baylor College of Medicine
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Myelodysplastic DisordersLeukemiaMultiple MyelomaPlasma Cell DyscrasiaLymphoproliferative Disorders
Start date
2000-06-01
Primary completion
2004-11-12
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.